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Introduction 
The grafting of reconstructed or ‘engineered’ functional mam-
malian tissue may be of great medical importance, because it
might compensate for missing tissue in the recipient, for
example in cases of congenital malformations, diseases leading
to tissue destruction, losses due to accidents or tissue ablation
as a consequence of surgery. In contrast to the transplantation
of donor organs, tissue engineering starts with cultured
proliferating cells and aims at reconstituting a tissue-like struc-
ture in culture. In case of solid tissues, a mere injection of cell
suspensions can rarely be expected to yield a functional replace-
ment. Rather, a macroscopic three-dimensional coherent cell
assembly is required for transplantation and this should have an
ordered internal structure similar to that of the authentic tissue
to be replaced. To achieve this, a biocompatible matrix or scaf-
fold is required that allows single cells to distribute and adhere,
to proliferate, and, if necessary, to finally differentiate and
mature to a functional state. Ideally, the transplanted scaffold
should slowly be degraded and replaced by an endogenous
extracellular matrix. In the case of engineered skeletal muscle, a
longitudinal order of the resulting muscle fibres is necessary for
the graft to generate directed force.
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Abstract 
Tissue engineering of skeletal muscle from cultured cells has been attempted using a variety of synthetic and natural macromolecular
scaffolds. Our study describes the application of artificial scaffolds (collagen sponges, CS) consisting of collagen-I with parallel pores
(width 20–50 µm) using the permanent myogenic cell line C2C12. CS were infiltrated with a high-density cell suspension, incubated in
medium for proliferation of myoblasts prior to further culture in fusion medium to induce differentiation and formation of multinucleated
myotubes. This resulted in a parallel arrangement of myotubes within the pore structures. CS with either proliferating cells or with
myotubes were grafted into the beds of excised anterior tibial muscles of immunodeficient host mice. The recipient mice were trans-
genic for enhanced green fluorescent protein (eGFP) to determine a host contribution to the regenerated muscle tissue. Histological
analysis 14–50 days after surgery showed that donor muscle fibres had formed in situ with host contributions in the outer portions of
the regenerates. The function of the regenerates was assessed by direct electrical stimulation which resulted in the generation of
mechanical force. Our study demonstrated that biodegradable CS with parallel pores support the formation of oriented muscle fibres
and are compatible with force generation in regenerated muscle.
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Several matrix materials have been examined for growth and
differentiation of myogenic cells in mass culture (cf. [1]) and for
the use in grafts. These included alginate hydrogels [2], fibrin gels
[3], polyglycolic acid meshes [4], poly(L-lactic acid) fibres [5],
sponge-like composites of poly(L-lactic acid) and polylactic-
glycolic acid [6], polypropylene fibres coated with laminin [7],
UV-embossed/micropatterned polyurethane diacrylate [8] and a
degradable block polyesterurethane [9]. In agreement with the
experience of many authors (e.g. [10, 11]) collagen-based
matrices or collagen coated surfaces supported growth and differ-
entiation of myogenic cells both in mass culture [1] and in grafts. 
The aim of the present work was to evaluate, in a first pilot
study, a highly ordered collagen-I-based scaffold and culture
conditions for myogenic cells as tools to efficiently graft muscle
precursor cells or immature muscle fibres (myotubes) into recip-
ient mice and to achieve the formation of skeletal muscle-like
tissue in situ. Scaffold cultures were analysed directly or after
grafting into a muscle bed of enhanced green fluorescent proteins
(eGFP) labelled nude host mice. The recipient eGFP label served to
distinguish host from donor cells [12]. The permanent mouse cell
line C2C12 was used as a model myogenic cell.
Furthermore, the present study aimed at demonstrating the
importance of the eGFP labelling of the host for the assessment of
the host and donor contributions of regenerates, respectively.
Material and methods 
Production and properties of collagen sponges
with oriented pores (CS) 
The preparation of collagen scaffolds with parallel oriented pores is based
on a patented ‘unidirectional freezing’ process of an aqueous dispersion
containing 1.5 wt% of porcine collagen fibres (mainly type I) and low
amounts of elastin followed by a freeze-drying process [13–15]. The colla-
gen dispersion is cooled and frozen using a defined temperature gradient
that is maintained during cooling. The temperature gradient is induced by
two heat sinks placed above and below the sample. By establishing two dif-
ferent homogeneous temperatures at the respective heat sinks (e.g. 35°C
and 5°C), a one-dimensional heat flow is created in the direction of the
temperature gradient. In order to freeze the dispersion, both heat sink tem-
peratures are lowered with the same cooling rate, leading to a directional
freezing of the ice crystals in the direction of the temperature gradient. By
adding an organic acid (e.g. acetic acid), the ice crystals are induced to
grow in a dendritic ice crystal morphology without side-branches. These
finger-shaped ice crystals sublime during freeze-drying, and oriented
pores result. The majority of the collagen fibres in the dispersion are
excluded from the ice crystals, and are concentrated between the ice fin-
gers thereby forming the final structure of the collagen scaffold.
The resulting parallel-layered structure of the dry collagen scaffold is
interconnected by collagen strands. The distance between the layers cor-
responds to the smallest pore size in the collagen scaffold. For optimal cell
seeding the pores have to be continuously interconnected throughout the
collagen sponge, which is the case for ‘unidirectional solidification’, and
the smallest pore size has to be large enough to allow the cells of interest
to migrate into the pore. Typically, a pore size distribution between 20 µm
and 50 µm was achieved (Fig.1).
Cells and culture media
As a source of myogenic cells, the C2C12 subline (ATCC CRL 1772, [16]) of
the permanent myogenic cell line C2 (derived from the C3H inbred mouse
strain; [17]) was used.
The basal medium was Dulbecco’s modified Eagle medium (DMEM)
with high glucose content (4.5 g/l; PAA Laboratories, Pasching, Austria),
supplemented with penicillin G (Biochrom AG Seromed, Berlin) and strep-
tomycin sulphate (Sigma, Taufkirchen, Germany).
For expansion, the medium was supplemented with 10% foetal calf serum
(FCS Gold, PAA) and termed proliferation medium (PM). To induce differenti-
ation, that is fusion into myotubes, PM was replaced by fusion medium (FM)
containing 2% FCS, 1% „Insulin-Transferrin-Selenium-A (100x)“ containing
670 µg/l sodium selenite, 11 g/l sodium pyruvate, 1 g/l insulin and 550 mg/l
transferrin (ITS-Supplement, Gibco Invitrogen, Carlsbad, USA). 
For expansion, cells were cultured in monolayer in 175 cm
2 Nunc
EasYFlask
TM tissue-culture flasks (Nunc, Roskilde, Denmark). 
Three-dimensional Cell-Matrix-Cultures were cultivated in hydrophobic
polystyrene Petri dishes of 40 mm diameter (Nunc).
The potential of the C2C12 cell line to yield spontaneously contractile
myotubes upon change to differentiation medium was assessed by cul-
turing in Matrigel
TM (BD Biosciences, Bedford, USA), a reconstituted
Fig. 1 Scanning electron micrograph showing the structure of the col-
lagen sponge used in this study. The orientation of the extended pores
(vertical in the micrograph) defined the longitudinal axis of the internal
structure of the sponge, in the transverse direction (horizontal in the
micrograph) there are connecting bridges and holes. Scale bar 100 µm.basement membrane matrix derived from murine tumour cells [18].
Sublines of C2C12 and the rat myogenic line L6 that did not develop into
highly contractile myotubes on Matrigel
TM tended to produce fast grow-
ing tumours when transplanted as collagen sponge (CS) cultures into the
muscle bed; they were therefore excluded from experiments on muscle
reconstitution.
Culture of myogenic cells in collagen sponges
Collagen-I sponges with pores of 20–50 µm diameter, oriented in paral-
lel and running through their whole thickness were used as scaffolds. To
colonize the CS with a maximum number of cells per volume, drops of
high-density cell suspensions (4 x 10
7/ml) were directly applied to dry
pieces of CS of approximately 6 mm x 3 mm x 2.5 mm size with a total
of 1.5 x 10
5 or 1.2 x 10
6 cells seeded. These were subsequently incubat-
ed at 37°C in a humid chamber to improve adherence before they were
covered with PM in plastic suspension culture dishes, which were not
coated to prevent outward migration of cells. Proliferation was allowed to
proceed for 1–7 days. Subsequently, the medium was changed to FM to
induce the fusion of C2C12 cells, resulting in the differentiation to
myotubes.
Host mouse strain and surgery
The mouse strain C57BL/6 Cr Slc TgN(act-EGFP)OsbC15-001-FJ001 trans-
genic for the enhanced green fluorescent protein of the jelly fish Aequoria
victoria [19] had been crossed into an NMRI-nu mouse strain. This hybrid
strain shows high concentrations of eGFP in all muscle types [20]. In order
to prevent graft rejection, nude (nu/nu) and eGFP transgenic individuals
were used as hosts for transplantation experiments [12, 20].
Reconstituted muscles in CS were grafted into the bed of the previ-
ously excised anterior tibial muscle (TA) using the transplantation proce-
dure previously described for donor muscles [12, 21]. The skin of the
lower leg was opened and deflected and the tibialis anterior (TA) and
extensor digitorum longus (EDL) muscles of the host animal were
removed under deep anaesthesia, using blunt scissors to reduce bleed-
ing. Subsequently, the CS (approximately of the size and shape of the TA)
was positioned in the muscle bed, and fixed at both ends by suturing it
to the remnant tissue under the knee and the distal tendon with a 6.0
thread. 100 µl of an analgetic (Metacam, Boehringer-Ingelheim,
Ingelheim/Rhein, Germany, 50 µg/ml in 0.9 % NaCl solution) were inject-
ed peritoneally during recovery from anaesthesia and again one day after
surgery. Animal experimentation was performed according to the
German law for the protection of animals, with a permit by the local
authorities. 
Physiology and histology
To assess the ability of the regenerates to generate force, isometric
contraction measurements on collagen sponge grafts using direct stim-
ulation were done as previously described for muscle grafts [22]. The
graft regenerated in the bed of the host TA was freed from surrounding
tissue up to the knee under deep anaesthesia. The (regenerated) tendon
was tied to a force transducer (300B-LR lever system, Aurora
Scientific, Vata Court, ON, Canada). Twitch (3-5 Hz), as well as incom-
plete (50 or 70 Hz) and complete (100 Hz) tetani were induced by direct
stimulation at 10 Volts via silver plate electrodes. Signals were ampli-
fied and visualized on a HAMEG 205-3 (HAMEG GmbH, D-60528
Frankfurt, Germany) oscilloscope. Data were recorded using a 80286
PC and evaluated with SigmaPlot (Jandel Scientific, San Rafael, CA,
USA) software.
Histology was done on fresh frozen sections as described elsewhere
[12]. Nuclei were stained with Hoechst dye 33258 (bisbenzimide, Sigma;
blue fluorescence). eGFP was fixed using the formaldehyde vapour method
[20, 23]. Sarcomeric myosin heavy chain (MyHC) was stained on adjacent
sections with the monoclonal murine antibody MF20 (ATCC [24]), laminin
with the polyclonal rabbit antibody L9393 (Sigma). As secondary antibod-
ies a TRITC-coupled goat antimouse (T 5393, Sigma) and a goat
anti-rabbit antibody coupled to Alexa Fluor 488 (Molecular Probes,
MoBiTec, Göttingen, Germany) were used.
Analysis and macroscopic observation was done using a Wild
stereomicroscope and a UV hand lamp, histological analysis with a Zeiss
Axiophot UV epifluorescence microscope (Zeiss, Jena, Germany), 
documentation was carried out in both cases with a Coolpix 990 camera
(Nikon), image processing was done using Photoshop CS2
(Adobe, USA).
Results 
Myotube formation in collagen sponges in culture
Sections of CS cultures (Fig. 2) revealed that myotubes had
formed in a parallel orientation according to the pore structure of
the scaffold (Fig. 2A). Differentiation of these myotubes was indi-
cated by their content in sarcomeric myosin, as shown by staining
with the monoclonal antibody MF20 (Fig. 2B). Furthermore,
myotubes in the CS had synthesized and deposited laminin, and
thus started to form their own extracellular matrix (Fig. 2C).
Maintenance of myotubes derived from C2C12 cells in CS was pos-
sible for at least 30 days.
Myotube formation and muscle
regeneration in transplanted CS 
CS colonized with C2C12 cells were transplanted into the bed of an
excised TA of nude host mice, either in the non-fused, proliferat-
ing state or after induction to fusion in culture. The host mice were
transgenic for eGFP. Due to technical limitations at the time of the
experiments only a fraction of the sponges had long enough pores
to be transplanted with the pores running longitudinally in the
muscle bed. However, properties other than contractility could be
studied in transversely oriented CS (cf. Table 1). 
1642 © 2008 The Authors
Journal compilation © 2008 Foundation for Cellular and Molecular Medicine/Blackwell Publishing LtdJ. Cell. Mol. Med. Vol 12, No 5A, 2008
1643 © 2008 The Authors
Journal compilation © 2008 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
External appearance and function
Recipient animals resumed normal gait after about 10 days post-
operatively (p.o.). They were sacrificed between 14 and 50 days
after surgery. When the skin was deflected from the operated leg,
the surface of the graft appeared reddish due to extensive vascu-
larization; it was distinct from that of the surrounding host mus-
cles by the absence of intense green fluorescence (Fig. 3A). The
tendon of the TA to which the graft had been fixed, was shown to
have regenerated (50 days p.o.).  Force measurement upon direct
electrical stimulation revealed twitch and tetanic tensions (Fig.3B
and C) in the range of 5–20% of an authentic adult TA  and were
comparable to those of regenerated transplanted TAs [22]. Time-
to-peak and half-relaxation times corresponded to those of fast
muscle of the mouse.
Fig. 2 C2C12-derived myotubes grown in collagen sponge in culture. Serial longitudinal frozen sections of 8 µm thickness were analysed. A 6 mm x
3 mm x 2.5 mm collagen sponge was soaked with 1.2 x 10
6 C2C12 cells, and cultured for 2 days in proliferation medium (PM) and subsequently for
5 days in fusion medium (FM) to induce myotube differentiation. (A) Haematoxylin–eosin stain to show collagen matrix (pink) and myotubes (pur-
ple). (B) Fluorescence image combining anti-myosin heavy chain (MF20, monoclonal anti-MyHC, red) with Hoechst staining of nuclei (blue). (C)
Fluorescence image of an anti-laminin stained section (green), showing the basal lamina of the myotubes. Scale bar in (C), 100 µm, 10 µm in inset.
Table 1 Grafting experiments using C2C12 myogenic cells in collagen
sponges and the bed of the anterior tibial (TA) muscle as a graft site
Cells + + 0 0
CS + + + 0
Orient. Transv. Longit. Longit. -
No. of Expt's 15 3 2 1
Myotubes/
myofibres
++ ++ 0 0
Immig.  + (+) (+) 0
Muscle reg. ++ ++ 0 0
Tumours 0 0 0 0Internal structure of C2C12-CS grafts
In cross-sections of regenerates, numerous immature and mature
muscle fibres were observed. Histology revealed residual CS up to
50 days after surgery, the cellular material in which was largely
eGFP negative, that is, of donor origin, but partially invaded by
regenerated host (eGFP positive) muscle fibres, regardless of
whether proliferating or pre-fused C2C12 cells had been transplanted.
Host and donor contributions to the regenerated muscle at the graft
site as well as possible co-fusion between host and donor cells were
scored on the basis of eGFP content. (Fig. 4A–E; cf. [12]). There
were large regions of myotubes and immature muscle fibres devoid
of eGFP and thus of solely donor origin (Fig.4A and B). Regenerated
fibres, regardless of their origin, had a much wider distribution of
diameters than original muscle fibres and the distributions of donor,
mixed and host-derived muscle fibres showed a broad overlap 
(Fig. 5). Most likely the smaller mean diameter of donor fibres
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Fig. 3 Anatomy and physiology of a
regenerated graft of C2C12 cells cultured
in collagen sponge (CS). The collagen
sponge (8 mm x 3 mm x 2.5 mm) was
seeded with 1.2 x 10
6 C2C12 cells, 
cultured for 1 day in PM and for 5 days in
FM, and grafted into the anterior tibial
(TA) bed of the enhanced green fluorescent
protein (eGFP) transgenic host mouse with
its pores longitudinally oriented. The graft
was analysed 50 d p.o. (A) External aspect
of the regenerate derived from the C2C12-
CS graft; g, graft; h, host; k, knee; arrow,
regenerated tendon.  Divisions of scale 1
mm. (B, C) Force generation upon direct
electrical stimulation in situ of regenerate
shown in (A). (B) twitch, stimulation 10 V,
3 Hz. (C) tetanus, stimulation 10 V, 100Hz
for 500 ms.J. Cell. Mol. Med. Vol 12, No 5A, 2008
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reflects a loss of the permanent C2C12 cell line to achieve the stage
of a fully mature muscle fibre (c.f. [25]). Fig.5 suggests that a high
density of seeding the C2C12 cells and the possibility to proliferate
after transplantation is more important for the calibre of resulting
muscle fibres than fusion prior to transplantation.
Controls
No tumour formation was observed when using differentiation
competent C2C12 cells, either proliferating or pre-fused in culture
(Table 1).
In the absence of the C2C12-CS graft no muscle regeneration
was observed in the muscle bed after removal of the TA [26].
When a CS without cells was implanted, there was some immigra-
tion by host cells from the margins but no myotube formation. 
Discussion
The role of the collagen matrix in our experiments is twofold:
First, it allows a large number of single cells to be placed into
a defined position in a muscle bed. This would obviously be
impossible using a cell suspension without a solid support to
which the cells adhere.
Second, the internal geometry of the matrix serves as an
ordered scaffold for the formation of a solid anisotropic tissue
from previously randomly suspended cells.
Fig. 4 Donor and host contributions to regenerated muscle derived from a graft of C2C12-CS (8 mm x 3 mm x 2.5 mm) seeded with 1.5 x 10
5 cells,
cultured for 2 days in PM and for 5 days in FM. Analysis 14 days after surgery. (A, B) Adjacent cross sections of the regenerated graft; (A) formalde-
hyde vapour fixed to show eGFP fluorescence (host label, green); (B) unfixed for immunostaining of myofibrillar myosin (red). Original host muscle
(h) is situated to the left, regenerated graft (g) to the right. Regenerating host muscle fibres have invaded the middle und right outer portion of the
graft, but myotubes and myofibres in large areas are eGFP negative and hence derived from donor- C2C12 cells only. (C, D) Enlargements of areas
indicated by dotted outline in (A) and (B), respectively. (E) Overlay of (C) and (D). In (C), regenerated myofibres, largely of host origin are recogniz-
able by high eGFP fluorescence and centrally located nuclei, indicating regeneration. They are surrounded by large numbers of eGFP-negative and
hence donor-derived immature muscle fibres and myotubes (D) and (E). Scale bar, 200 µm in (A) and (B), 50 µm in (C, D) and (E).Specifically, our results suggest that CS with parallel pores
are promising scaffolds for muscle tissue engineering. This
stands in contrast to previous studies attempting to engineer the
ordered structure of skeletal muscle from cells suspended in
gels. In one attempt, C2C12 cells were embedded in single solid
cylinders (diameters <1mm) consisting of a solidifying collagen
type I gel [11], in which the orientation of myotubes in parallel
was achieved in a second step by mechanical stretching. In
another study, myotubes resulting from in fibrin gel seeded
myoblasts oriented themselves through self-contraction [3].
However, it is unclear if such an unstructured gel construct
would also support subsequent alignment of host-derived
myotubes resulting from immigrated host myoblasts upon graft-
ing in situ. In contrast the application of CS with oriented inter-
nal pores, results in an artificial tissue section with hundreds or
thousands of host, as well as graft derived myotubes automati-
cally oriented in parallel in a global scale.
In the present study, C2C12 cells pre-cultured in CS (non-
fused or fused) when grafted into a muscle bed were shown to
  develop into more mature stages than in culture and to
  contribute to regenerating muscle, capable of producing con-
tractile force. In order to simulate a clinically relevant situation,
we have not used -irradiation of the recipient limb to eliminate
a contribution by host myogenic cells to the regeneration of the
excised muscle. In case of a muscle deficit due to a hereditary
muscle disease it is desirable that the normal genetic constitu-
tion of implanted cells should, by co-fusion with host myoblasts,
convey that condition to regenerating host tissue (e.g. [27]).
In contrast to most transplantation experiments, the present
work uses a ‘negative labelling’ of the donor cells, that is absence
of the eGFP label (cf. [12]). In conjunction with cell fusion during
myogenesis and the high diffusibility of eGFP within a given mus-
cle fibre [12] the eGFP labelling of host muscle provides an
extremely sensitive measure for host contributions to the regener-
ated muscle fibres at the graft site. Fibres of mixed donor-host ori-
gin can be recognized by their intermediate levels of eGFP. Ideally
there should be complementary markers for donor and recipient,
for example nLacZ and eGFP transgenes [12]. Due to the 
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Fig. 5 Diameters of muscle fibres and myotubes within regenerated C2C12-CS grafts, 14 days post-operatively (p.o.). Frozen sections stained with anti-
bodies against sarcomeric myosin heavy chain (MF20) and laminin were used for measurements of fibre diameters. 255 fibres (from two experiments)
were classified according to their eGFP fluorescence: eGFP negative (donor derived, circles), intermediate (triangles, derived from co-fusion of host and
donor cells), high eGFP (squares, host derived). Experiment 1 (full symbols): seeding of CS with 1.2 x 10
6 cells, cultured for 7 days in PM; experiment
2 (empty symbols): CS seeded with 1.5 x 10
5 cells, cultured for 2 days in PM followed by 5 days in FM; same experiment as shown in Figure 4.J. Cell. Mol. Med. Vol 12, No 5A, 2008
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phenomenon of co-fusion in muscle grafts, a host label, especially
with the highly diffusible eGFP allows for a more stringent evalu-
ation of the donor contribution than a donor label (cf. [12, 20]).
Outlook
In future experiments, expanded satellite cells (myogenic stem
cells) rather than a permanent cell line should be used in order to
achieve a higher degree of maturation in the CS. At the same time,
CS with wider and longer pores, which are in the process of being
developed, should be used; in principle it should be possible to
achieve pore sizes up to 100 µm by applying appropriate freezing
parameters in the directional freezing process [28]. A further
refinement would be the use of ordered CS, as described in this
paper, in conjunction with either a supplementation with growth
factors [29, 30], or non-myogenic cells (e.g. fibroblasts) [6] or
both to improve the integration at the host site and to promote
vascularization. Furthermore, appropriate host nerves should be
surgically directed into the graft in order to achieve motor and
sensory innervation.
Conclusions
In this pilot study we have shown that the use of a novel collagen
sponge with oriented pores offers a most promising method for
the engineering of at least small muscles, provided that it is seed-
ed at very high cell density. In future experiments, expanded satel-
lite cells (myogenic stem cells) rather than a permanent cell line
should be used in order to achieve a higher degree of maturation
in CS with wider and longer pores.
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